J. Goldman & Co’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.91M Buy
1,680,752
+733,449
+77% +$4.52M 0.26% 118
2025
Q4
$7.31M Buy
947,303
+533,431
+129% +$4.75M 0.19% 146
2025
Q3
$3.65M Sell
413,872
-2,040,647
-83% -$15.2M 0.09% 230
2025
Q2
$10.2M Buy
2,454,519
+2,277,282
+1,285% +$14.3M 0.24% 136
2025
Q1
$1.07M Buy
+177,237
New +$1.08M 0.03% 358
2021
Q3
Sell
-4,500
Closed -$220K 476
2021
Q2
$220K Sell
4,500
-43,547
-91% -$1.82M 0.01% 356
2021
Q1
$1.42M Buy
+48,047
New +$1.35M 0.05% 270

Other funds holding VSTM

J. Goldman & Co's VSTM Position: Q1 2026 in Review

J. Goldman & Co increased its Verastem (VSTM) stake by 77% in Q1 2026, buying an estimated $4.52M and bringing the position to 1,680,752 shares worth $8.91M. The position accounts for 0.26% of the portfolio, ranked #118.

J. Goldman & Co first reported a position in VSTM in Q1 2021 and has held it in 7 quarters since. The position peaked at $10.2M in Q2 2025. 155 funds tracked by Wall St. Rank hold VSTM as of Q1 2026.

  • J. Goldman & Co held 1,680,752 shares of Verastem worth $8.91M as of Q1 2026.
  • J. Goldman & Co bought 733,449 Verastem shares in Q1 2026, an estimated $4.52M.
  • Verastem made up 0.26% of J. Goldman & Co's portfolio in Q1 2026, its #118 holding.
  • J. Goldman & Co first reported a position in Verastem in Q1 2021 and has held it in 7 quarters since.
  • J. Goldman & Co's Verastem position peaked at $10.2M in Q2 2025.
  • 155 funds tracked by Wall St. Rank held Verastem as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.